compounded semaglutide crackdown news october 2025 The market for GLP-1 drugs remained robust despite the end of (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) shortages, with many facilities adding ingredients like B vitamins and some operating with Chinese companies turn to generics

But for many active adults, it can be part of a smart muscle-supportive routine

Tirzepatide, the GLP-1 in Zepbound and Mounjaro, contributed to Eli Lilly passing US$1 trillion in market capitalization on November 21, 2025 the first healthcare company in history to cross that threshold

The documentation includes purity verification, identity confirmation and relevant analytical data that researchers need for experimental planning and regulatory compliance

Semaglutide meds such as Ozempic or Wegovy can help patients lose weight and slightly lower their risk of having a cardiovascular event, but due to the potential side effects and cost, these medications are definitely not first-line treatments for most people with cardiovascular disease